Hap Trading, LLC Precigen, Inc. Transaction History
Hap Trading, LLC
- $935 Billion
- Q1 2025
A detailed history of Hap Trading, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 14,800 shares of PGEN stock, worth $20,276. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,800Holding current value
$20,276% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PGEN
# of Institutions
153Shares Held
164MCall Options Held
1.11MPut Options Held
36.8K-
Third Security, LLC83.5MShares$114 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.4MShares$23.8 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$15.4 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.8MShares$12.1 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $285M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...